SCHEMBL22453567

SCHEMBL22453567

CN(c1ccc(C2CCCCC2)cc1)c1ccc(N)cn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSMB5 P28074 1/20 0.45
KDM4E B2RXH2 1/20 0.38
GLA P06280 1/20 0.38
HTT P42858 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HIF1A Q16665 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
BACE1 P56817 1/20 0.38
DGAT1 O75907 2/20 0.36
ADK P55263 2/20 0.35
SLC18A3 Q16572 2/20 0.35
NOS3 P29474 2/20 0.35
NOS1 P29475 2/20 0.35
NOS2 P35228 2/20 0.35
CYP11B2 P19099 1/20 0.33
KDM6B O15054 1/20 0.33
KDM4C Q9H3R0 1/20 0.33
HAO1 Q9UJM8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22452599 0.93 PSMB5 (0.46) PSMB5KDM4EGLAHTTKMT2A
SCHEMBL22452611 0.83 PSMB5 (0.42) PSMB5KDM4EGLAHTTKMT2A
SCHEMBL22453195 0.82 SLC18A3 (0.44) PSMB5KDM4EGLAHTTKMT2A
SCHEMBL30639141 0.82 ALDH1A1 (0.43) KDM4ETDP1L3MBTL1KDM4C
SCHEMBL22453569 0.80 PSMB5 (0.42) PSMB5KDM4EGLAHTTKMT2A
SCHEMBL22453373 0.80 PSMB5 (0.38) PSMB5KDM4EGLAHTTKMT2A
SCHEMBL22453369 0.79 PSMB5 (0.41) PSMB5KDM4EGLAHTTKMT2A
SCHEMBL22452582 0.77 CYP3A4 (0.43) PSMB5TDP1L3MBTL1BACE1SLC18A3
SCHEMBL20210323 0.77 SLC18A3 (0.46) PSMB5HTTKMT2ASMN1; SMN2TDP1
SCHEMBL22405891 0.76 KDM4E (0.50) PSMB5KDM4EGLAHTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020190774-A1 NOVEL SMALL MOLECULE INHIBITORS OF TEAD TRANSCRIPTION FACTORS THE GENERAL HOSPITAL CORPORATION (US) 2020-09-24 WO disclosed